Hib-DTaP vaccine - sanofi pasteurAlternative Names: Hib-DTP-acellular vaccine - sanofi pasteur; TriHIBit
Latest Information Update: 19 Jan 2005
At a glance
- Originator sanofi pasteur
- Class Haemophilus vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Marketed Diphtheria; Haemophilus infections; Pertussis; Tetanus
Most Recent Events
- 19 Jan 2005 Aventis Pasteur is now called sanofi pasteur
- 27 Aug 2004 Aventis has merged with Sanofi-Synthelabo to form Sanofi-Aventis
- 24 Dec 1999 Pasteur Mérieux Connaught is now a subsidiary of Aventis and its new name is Aventis Pasteur